Protective effect of extract of Boerhaavia diffusa and Silybum marianum in combination against fructose induced non‑alcoholic fatty liver in rats
DOI:
https://doi.org/10.22377/ijgp.v7i3.328Abstract
Aim: The present study was undertaken with a view to validate the traditional use of Boerhaavia diffusa (BEE) root and Silybum marianum (SME) seeds in combination as a hepatoprotective agent against non‑alcoholic fatty liver disease. Materials and Methods: The alcoholic extracts of BEE roots (150 mg/kg, p.o.) and SME (150 mg/kg, p.o.) seeds were administered to the experimental rats individually and in combination (75 mg/kg + 75 mg/kg), p.o. by dispersing it in 1% tween 80, were given, of different groups respectively. After intoxication withhigh fructose diet (HFD) fructose solution to the animals orally for 6 weeks serum levels of various enzymes were recorded. Serum levels of aspartate transaminase (AST), alanine amino transaminase (ALT), alkaline phosphatase (ALP), total bilirubin (TB), total protein and cholesterol (CHO) level were assessed. Results: BEE roots and SME seeds extracts exhibited a significant hepatoprotective effect as evident from the decreases of serum AST, ALT, ALP, TB and CHO and increases in levels of TP compared with control group (P < 0.01 or P < 0.05).
The effect of combination of both the extract exerts more hepatoprotective as revealed by more level of significance. Conclusions: The present finding suggests that the hepatoprotective effect of BEE roots and SME seeds extract.
Key words: Boerhaavia diffusa, fructose, hepatoprotective, non‑alcoholic fatty liver, silybum marianum
Downloads
References
Shanmugarajan TS, Sivaraman D, Somasundaram I, Arunsundar M,
Krishnakumar E, Balaji R, et al. Influence of alpha lipoic acid on
antioxidant status in D‑galactosamine‑induced hepatic injury.
Toxicol Ind Health 2008;24:635‑42.
Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic
steatohepatitis: Mayo clinic experiences with a hitherto unnamed
disease. Mayo Clin Proc 1980;55:434‑8.
RodrÃguez‑Hernández H, Gonzalez JL, Márquez‑Ramirez MD,
Flores‑Hernandez M, RodrÃguez‑Morán M, Guerrero‑Romero F.
Risk factors associated with nonalcoholic fatty liver disease
and its relationship with the hepatic histological changes. Eur J
Gastroenterol Hepatol 2008;20:399‑403.
Verrijken A, Francque S, Van Gaal L. The metabolic syndrome and
the liver. Acta Gastroenterol Belg 2008;71:48‑59.
Stefan N, Kantartzis K, Häring HU. Causes and metabolic
consequences of Fatty liver. Endocr Rev 2008;29:939‑60.
Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C,
American Heart Association, et al. Definition of metabolic
syndrome: Report of the National Heart, Lung, and Blood Institute/
American Heart Association conference on scientific issues related
to definition. Circulation 2004;109:433‑8.
Stern MP, Williams K, González‑Villalpando C, Hunt KJ,
Haffner SM. Does the metabolic syndrome improve identification
of individuals at risk of type 2 diabetes and/or cardiovascular
disease? Diabetes Care 2004;27:2676‑81.
Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS,
Thomas GN, et al. Factor analysis of the metabolic syndrome:
Obesity vs insulin resistance as the central abnormality. Int J Obes
Relat Metab Disord 2001;25:1782‑8.
Holvoet P. Relations between metabolic syndrome, oxidative
stress and inflammation and cardiovascular disease. Verh K Acad
Geneeskd Belg 2008;70:193‑219.
Angulo P, Lindor KD. Treatment of nonalcoholic fatty liver: Present
and emerging therapies. Semin Liver Dis 2001;21:81‑8.
Drenick EJ, Simmons F, Murphy JF. Effect on hepatic morphology
of treatment of obesity by fasting, reducing diets and small‑bowel
bypass. N Engl J Med 1970;282:829‑34.
CSIR. The Wealth of India: Raw Materials. Vol. 7B. CSIR:
New Delhi, India; 1988. p. 174.
Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN, Ray C. Screening of
Indian plants for biological activity: I. Indian J Exp Biol 1968;6:232‑47.
Chandan BK, Sharma AK, Anand KK. Boerhaavia diffusa: A study
of its hepatoprotective activity. Indian J Exp Biol 1991;31:299‑307.
Rawat AK, Mehrotra S, Tripathi SC, Shome U. Hepatoprotective
activity of Boerhaavia diffusa L. roots – A popular Indian
ethnomedicine. J Ethnopharmacol 1997;56:61‑6.
Gaitonde BB, Kulkarni HJ, Nabar SD. Diuretic activity of
punarnava (Boerhaavia diffusa). Bull Haffkine (Bombay, India)
;2:24.
Bhalla TN, Gupta MB, Sheth PK, Bhargava KP. Anti‑inflammatory
activity of Boerhaavia diffusa. Indian J Physiol Pharmacol
;12:37.
Jain GK, Khanna NM. Punarnavoside: A new antifibrinolytic agent
from Boerhaavia diffusa. Indian J Chem 1989;28:163‑6.
Adesina SK. Anticonvulsant properties of the roots of Boerhaavia
diffusa. Q J Crude Drug Res 1979;17:84‑6.
Olukoya DK, Idika N, Odugbemi T. Antibacterial activity
of some medicinal plants from Nigeria. J Ethnopharmacol
;39:69‑72.
Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB.
Anticancer potential of silymarin: From bench to bed side.
Anticancer Res 2006;26:4457‑98.
Giese LA. Milk thistle and the treatment of hepatitis. Gastroenterol
Nurs 2001;24:95‑7.
Jeong DH, Lee GP, Jeong WI, Do SH, Yang HJ, Yuan DW, et al.
Alterations of mast cells and TGF‑beta1 on the silymarin treatment
for CCl (4)‑induced hepatic fibrosis. World J Gastroenterol
;11:1141‑8.
Zielińska‑Przyjemska M, Wiktorowicz K. An in vitro study of the
protective effect of the flavonoid silydianin against reactive oxygen
species. Phytother Res 2006;20:115‑9.
Dehmlow C, Erhard J, de Groot H. Inhibition of Kupffer cell
functions as an explanation for the hepatoprotective properties
of silibinin. Hepatology 1996;23:749‑54.
Mukherjee PK. Quality Control of Herbal Drugs. Culcu􀄴 a: Business
Horizons; 2002. p. 184-205, 529-34, 562-7.
OECD Guideline for testing of chemicals, acute oral toxicity – Fixed
dose procedure, 420. Organization for economic co-operation and
development; 2001.
Sharma A, Chakraborti KK, Handa SS. Anti hepatotoxic activity
of some Indian herbal formulations as compared to silymarin.
Fitoterapia 1991;62:229-35.
Reitman S, Frankel S. A colorimetric method for the determination
of serum glutamic oxalacetic and glutamic pyruvic transaminases.
Am J Clin Pathol 1957;28:56-63.
Henary RJ, Cannon DC, Winkleman JW. Clinical Chemistry
Principles and Techniques. 2nd ed. Maryland: Harper and Roe; 1974.
Fredrikson DS, Levi RL, Less RS. Determination of cholesterol.
N Engl J Med 1967;276:148-56.
Shrivastava N, Padhya MA. “Punarnavine†profile in the
regenerated roots of Boerhaavia diff usa L. from leaf segments. Curr
Sci 1995;68:653-6.
Luper S. A review of plants used in the treatment of liver disease:
Part 1. Altern Med Rev 1998;3:410-21.
Stipanuk MH. Biochemical, Physiological, and Molecular
Aspects of Human Nutrition. 2nd ed. Philadelphia, PA: Elsevier,
W.B. Saunders; 2006.
Wikipedia, the free encyclopedia; fructose. Available from:
h􀄴 p://en.wikipedia.org/wiki/Fructose# citenote-22. [Last accessed
on 2010 Oct 25].
Chaudhari BP, Chaware VJ, Joshi YR, Biyani KR. Hepatoprotective
activity of hydroalcoholic extract of Momordica charantia Linn.
leaves against carbon tetra chloride induced hepatopathy in rats.
Int J ChemTech Res 2009;1:355-8.
